Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
about
Atypical antipsychotics in bipolar disorder: systematic review of randomised trialsEfficacy of antimanic treatments: meta-analysis of randomized, controlled trialsPublication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorderThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmBipolar disorder.Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysisThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?Ziprasidone in the treatment of mania in bipolar disorder.Acute and long-term treatment of mania.Effect of initial ziprasidone dose on treatment outcome of korean patients with acute manic or mixed episodes.Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.Pharmacological treatment of mixed states.Ziprasidone: efficacy and safety in patients with bipolar disorder.Evidence review and clinical guidance for the use of ziprasidone in Canada.Emerging drugs for bipolar disorder.Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trialAdjunctive treatment of acute mania: a clinical overview.Comparison of mania patients suitable for treatment trials versus clinical treatmentAntipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorderZiprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.A UK consensus on the administration of aripiprazole for the treatment of mania.Treating bipolar disorder in the primary care setting: the role of aripiprazole.Strategies for successful clinical management of schizophrenia with ziprasidone.Drug safety evaluation of ziprasidone.Ziprasidone for maintenance treatment of bipolar I disorder in adults.Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials.Refractoriness in bipolar disorder: definitions and evidence-based treatment.Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.Treatment of mixed bipolar states.Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder.Efficacy of antimanic treatments in mixed states.The clinical management of bipolar disorder complexity using a stratified model.Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.Role of atypical antipsychotics in the treatment of generalized anxiety disorder.Clinical decision making in the treatment of mixed states.
P2860
Q21260276-5921E163-7796-42D8-A9ED-7F9755572D2BQ24601815-79B7BBD0-AE64-40AB-8E89-44E9F7A5EB86Q24643545-276E62A2-1A48-4588-945C-716E6F2124D3Q28066714-8D411257-14D1-4861-B909-65F92505FABDQ33448290-BDC1BD63-063B-4D0C-ACF2-A1B19F9576BFQ33529314-90BD332A-0347-4299-8649-4FA23C25DF17Q34606256-8FCEB1FB-590E-44CE-BFB1-40638CFE0315Q34649187-A8F8D18D-DB71-41EF-BDF7-48B609D149F8Q34809427-514D5885-0A5C-44F5-8787-4686CA346865Q34966022-3EAEB2F9-31E2-459D-B92B-2F6AF6AF210DQ35236966-E1984A61-476D-43B9-8034-AD2D4F708B50Q35238333-63D3EDA8-1788-4FBA-BBBE-92456798B79BQ36162402-F7F35C80-48B4-4373-AEDB-6A31EAC1C2E4Q36349023-4211E68A-B524-472A-8E79-95DBCE45F3AAQ36558654-5D6CA8A5-784F-42A9-BEE6-809CB1AFB436Q36588607-8FB6C80A-8ABF-45A6-BBCE-8BE58FD5A4EDQ36634257-1E0131C7-A081-4660-8EFC-6D70F365B3AFQ36780394-E53F34BF-68F0-46A0-B112-41923488AE98Q36905879-9364197A-FCB8-4454-85C7-3ADC68008893Q37100104-0F14718D-3B14-475D-971D-5BB3F4D8A2C9Q37111491-9E03D902-9367-42C5-BE36-A772724E823AQ37244172-896491A8-7CFA-480E-BFA9-72F995BF9879Q37244876-CD030424-9838-4E49-B76F-EF083DDFF6FFQ37326130-E4FE0A47-AF5B-40B6-9C3B-AA46CF113024Q37429721-991CAC7D-4619-41F8-AF7A-48A0FCF1A8DEQ37775630-3756E570-337E-47C3-8F2B-B3F3F9C5C33AQ37844574-1D8EB4A3-17A8-4506-BF13-293CCB7F6BC6Q37850820-A1D132C6-E76B-4C1B-90B1-9891D921BE57Q37908140-45568FDD-9C07-4929-9F5A-17B419C9EB3CQ37933405-E3FAF00D-D744-4EA3-A0E6-7DA95CFA8F8EQ37954423-2EA3AA5D-ECD9-4266-90A1-C5061A71AAB0Q37960632-7D055588-97A2-4B28-8B18-0F09B503306AQ37973144-6B5DB21B-495B-45DF-B0C0-C3E0F5EFD62AQ38003196-51F00C50-7761-4F25-89BA-1D3B231FB44EQ38003197-596759AB-F1B0-4161-9EAC-84FB35232EADQ38003199-FDD71A3A-47B2-4725-A7EC-EA99D0DF9026Q38077281-25E0D159-DF11-4557-A37A-CC0F8CF65516Q38132709-E73EB017-37F8-4D6A-9614-CF8C940794BCQ38209188-318267DB-0BE8-440C-ACAC-FF41ADB33910Q38211511-4E710220-0F48-41F7-9DF1-7DA9FDEA5570
P2860
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Ziprasidone in acute bipolar m ...... -controlled replication trial.
@en
Ziprasidone in acute bipolar m ...... -controlled replication trial.
@nl
type
label
Ziprasidone in acute bipolar m ...... -controlled replication trial.
@en
Ziprasidone in acute bipolar m ...... -controlled replication trial.
@nl
prefLabel
Ziprasidone in acute bipolar m ...... -controlled replication trial.
@en
Ziprasidone in acute bipolar m ...... -controlled replication trial.
@nl
P2093
P1476
Ziprasidone in acute bipolar m ...... -controlled replication trial.
@en
P2093
Kathleen Ice
Patricia English
Paul E Keck
Scott Segal
P304
P356
10.1097/01.JCP.0000169068.34322.70
P407
P577
2005-08-01T00:00:00Z